K191899: Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K191899 (Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions, cleared 2019-08-16 for Roche Diagnostics) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K191899
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK191899
Cleared Device Trade / Generic NameGlucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions
FDA Applicant on FilingRoche Diagnostics
FDA 3-Letter Product ClassificationProduct Code CFR
FDA Substantial Equivalence Decision Date2019-08-16
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Roche / Genentech across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Roche Diagnostics, compare peer devices under FDA Product Code CFR, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.